bioRxivBiochemistry
A multi-parameter optimization in middle-down analysis of monoclonal antibodies by LC-MS/MS
J. S. Dhenin, M. Dupre, K. Druart, A. Krick, C. Mauriac, J. Chamot-Rooke
Abstract
In antibody-based drug research, regulatory agencies request a complete characterization of antibody proteoforms covering both the amino acid sequence and all post-translational modifications. The usual mass spectrometry-based approach to achieve this goal is bottom-up proteomics, which relies on the digestion of antibodies, but does not allow the diversity of proteoforms to be assessed. Middle-down and top-down approaches have recently emerged as attractive alternatives but are not yet mastered and thus used in routine by many analytical chemistry laboratories. The work described here aims at providing guidelines to achieve the best sequence coverage for the fragmentation of intact light and heavy chains generated from a simple reduction of intact antibodies using Orbitrap mass spectrometry. Three parameters were found crucial to this aim: the use of an electron-based activation technique, the multiplex selection of precursor ions of different charge states and the combination of replicates.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Direct Measurement of Light and Heavy Antibody Chains Using Differential Ion Mobility Spectrometry and Middle-Down Mass Spectrometry
R. D. Melani, K. Srzentic, … N. L. Kelleher·bioRxiv·Jul 5, 2019
- Systematic benchmarking of mass spectrometry-based antibody sequencing reveals methodological biases
Maria Chernigovskaya, Khang Lê Quý, … Victor Greiff·Cell SystemsPeer-reviewed·Nov 1, 2025
- Mass spectrometry-based sequencing of the anti-FLAG-M2 antibody using multiple proteases and a dual fragmentation scheme
W. Peng, M. F. Pronker, J. Snijder·bioRxiv·Jan 7, 2021
- Deep Proteoform Sequencing with Top-Down Direct Mass Technology
Kenneth R. Durbin, Taojunfeng Su, … Neil L. Kelleher·bioRxiv·Jun 3, 2026
- Increasing Applicability of Automated mD-LC-MS Peptide Mapping for Biopharmaceuticals via Streamlined In-Solution Digestion
Christoph Gstöttner, Tao Zhang, … Elena Domínguez‐Vega·bioRxiv·Sep 4, 2025
- A prototype timsOmni platform enables confident annotation of key hypervariable regions of IgG immunoglobulins using low- and high-energy electron-based fragmentation.
Simon Ollivier, Dina Schuster, … Albert J. R. Heck·bioRxiv·Oct 29, 2025